The 5′ ppp-siRNA for transforming growth factor beta (TGF-β), which is a cytokine playing a central role in tumor-induced immunosuppression and tumor progression in pancreatic cancer, was also developed for pancreatic cancer therapy. This evidence concerns the gene TGFB1 and familial pancreatic carcinoma.